[Indications for the eradication of Helicobacter pylori. Reflections on the Maastricht consensus conference]

Gastroenterol Hepatol. 1998 Jan:21 Suppl 1:29-34.

[Article in Spanish]

Authors

D Boixeda de Miquel¹, C Martín de Argila, J Pérez Gisbert

Affiliation

¹ Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid.

PMID: 9549200

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Chronic Disease
Clinical Trials as Topic
Consensus Development Conferences as Topic
Duodenal Ulcer / drug therapy
Duodenal Ulcer / etiology
Dyspepsia / drug therapy
Dyspepsia / etiology
Female
Gastritis / drug therapy
Gastritis / etiology
Helicobacter Infections / complications
Helicobacter Infections / drug therapy*
Helicobacter pylori*
Humans
Lymphoma, B-Cell, Marginal Zone / etiology
Male
Netherlands
Recurrence
Risk Factors
Stomach Neoplasms / etiology
Stomach Ulcer / drug therapy
Stomach Ulcer / etiology

Substances

Anti-Inflammatory Agents, Non-Steroidal